Kadant (NYSE:KAI) Stock, Quote.Headers.trade-ideas

Kadant

Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence with sizable revenue from the U.S., Europe, Asia, and Canada.

Earnings

Earnings Beats

News

Markets

Analyst Ratings

Trading Ideas

IDEX Corporation&#39;s (NYSE: IEX) second-quarter 2024 adjusted earnings of $2.06 per share surpassed the Zacks Consensus Estimate of $2.04. The bottom line decreased approximately 6% from the year-ago quarter&#39;s earnings of $2.18 per share.

IDEX Q2 Earnings Top Estimates, Sales Miss, &#39;24 View Down

For those looking to find strong Industrial Products stocks, it is prudent to search for companies in the group that are outperforming their peers. Barnes Group (NYSE: B) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole?

Is Barnes Group Stock Outpacing Its Industrial Products Peers This Year?

Penny Stocks

Small Cap

Intraday Update

Movers

AMWL

APPN

BBIO

BPMC

CGNX

COIN

CRSP

DNOW

DTSS

DWAC

EPAM

FROG

INFA

LYFT

NNOX

PEGA

PTEN

SHAK

SLVM

SOUN

SPWR

ULBI

ZBRA

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Wednesday.

Reliance Steel &amp; Aluminum Posts Upbeat Earnings, Joins JFrog, AppLovin, Shake Shack And Other Big Stocks Moving Higher On Thursday

Kadant Inc

KardiaChain

KAIROS MINERALS LTD ORD by Kairos Minerals Ltd.

Kairos Minerals Ltd

KAWASAKI KISEN UNS/ADR by Kawasaki Kisen Kaisha, Ltd.

Kawasaki Kisen Kaisha Ltd

Kainos Group PLC

Kairos Pharma, Ltd

Kairous Acquisition Corp. Limited - Ordinary Shares

Kairous Acquisition Corp Ltd

Kairous Acquisition Corp. Limited - Warrants

Kairous Acquisition Corp. Limited - Rights

KAISA PROSPERITY HOLDINGS by Kaisa Prosperity Holdings Ltd.

Kaisa Prosperity Holdings Ltd

Kaiser Aluminum Corporation - Common Stock

Kaiser Aluminum Corp

KAISER GRP HLDGS INC by Kaiser Group Holdings, Inc.

Kaiser Group Holdings Inc

Kaiser Reef Ltd

Kaival Brands Innovations Group, Inc. - Common Stock

Kaival Brands Innovations Group Inc

Kaixin Auto Holdings Warrants (30/04/2024)

Kaixin Holdings

Kaizen Discovery Inc

<p>Making a noteworthy insider sell on August 28, <strong>JOHN ALBERTINE</strong>, Director at <strong>Kadant</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>), is reported in the latest SEC filing.</p>
<p><strong>What Happened:</strong> ALBERTINE's decision to sell 250 shares of <strong>Kadant</strong> was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000886346/000088634624000136//Archives/edgar/data/886346/000088634624000136/0000886346-24-000136-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday. The total value of the sale is $80,393.</p>
<p>The latest update on Thursday morning shows <strong>Kadant</strong> shares down by 0.0%, trading at $318.6.</p>
<h3>Discovering Kadant: A Closer Look</h3>
<p>Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, &amp; filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence with sizable revenue from the U.S., Europe, Asia, and Canada.</p>
<h3>Financial Milestones: Kadant's Journey</h3>
<p><strong>Revenue Growth:</strong> Kadant's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately <strong>12.12%</strong>. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Industrials sector.</p>
<p><strong>Analyzing Profitability Metrics:</strong></p>
<ul>
<li>
<p><strong>Gross Margin:</strong> The company excels with a remarkable gross margin of <strong>44.36%</strong>, indicating superior cost efficiency and profitability compared to its industry peers.</p>
</li>
<li>
<p><strong>Earnings per Share (EPS):</strong> Kadant's EPS is significantly higher than the industry average. The company demonstrates a robust bottom-line performance with a current EPS of <strong>2.66</strong>.</p>
</li>
</ul>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.43</strong>.</p>
<p><strong>Valuation Metrics: A Closer Look</strong></p>
<ul>
<li>
<p><strong>Price to Earnings (P/E) Ratio:</strong> The Price to Earnings ratio of <b><strong>32.78</strong></b> is lower than the industry average, indicating potential undervaluation for the stock.</p>
</li>
<li>
<p><strong>Price to Sales (P/S) Ratio:</strong> A higher-than-average P/S ratio of <strong>3.72</strong> suggests overvaluation in the eyes of investors, considering sales performance.</p>
</li>
<li>
<p><strong>EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization):</strong> Kadant's EV/EBITDA ratio stands at <strong>19.09</strong>, surpassing industry benchmarks. This places the company in a position with a higher-than-average market valuation.</p>
</li>
</ul>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><a href="https://www.schwab.com/brokerage?aff=XEC"><em>Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</em></a></p>
<h3>The Importance of Insider Transactions</h3>
<p>It's important to note that insider transactions alone should not dictate investment decisions, but they can provide valuable insights.</p>
<p>Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.</p>
<p>The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.</p>
<p>However, insider sells may not always signal a bearish view and can be influenced by various factors.</p>
<h3>A Deep Dive into Insider Transaction Codes</h3>
<p>Taking a closer look at transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, meticulously cataloged in Table I of the Form 4 filing. A <strong>P</strong> in Box 3 denotes a purchase, while <strong>S</strong> signifies a sale. Transaction code <strong>C</strong> denotes the conversion of an option, and transaction code <strong>A</strong> signifies a grant, award, or other acquisition of securities from the company.</p>
<p><a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000886346"><strong>Check Out The Full List Of Kadant's Insider Trades.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Insider Trades

Insider Transaction: JOHN ALBERTINE Sells $80K Worth Of Kadant Shares

WIIM

Kadant shares are trading lower. The company reported Q2 financial results and issued Q3 EPS and revenue guidance with a midpoint below estimates.

<p><strong>IDEX Corporation</strong>&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iex#NYSE">IEX</a>) second-quarter 2024 adjusted earnings of $2.06 per share surpassed the Zacks Consensus Estimate of $2.04. The bottom line decreased approximately 6% from the year-ago quarter&#39;s earnings of $2.18 per share. However, it exceeded management&#39;s projection of $2.00-$2.05 per share.</p>
<h3>Revenue Details</h3>
<p>IDEX&#39;s net sales of $807.2 million missed the Zacks Consensus Estimate of $831 million.&nbsp; The top line also decreased 5% year over year. Organic sales decreased 4% year over year. Foreign currency translation had a negative impact on sales by 1%.</p>
<p>IEX reports net sales under three business segments, the results of which are discussed below:</p>
<p>Net sales from the Fluid &amp; Metering Technologies segment totaled $319.4 million, down 2% year over year. Our estimate for segmental net sales was $327 million. While organic sales were flat year over, acquisition/divestitures and foreign currency translation each had a negative impact of 1% on sales.</p>
<p>Net sales from the Health &amp; Science Technologies segment totaled $303.8 million, indicating a year-over-year decline of 11%. Our estimate for segmental net sales was $321 million. Organic sales declined 11% year over year.</p>
<p>Net sales from the Fire &amp; Safety/Diversified Products segment totaled $185.4 million, which increased marginally year over year. Our estimate for segmental net sales was $185 million. Organic sales increased 1% on a year-over-year basis while foreign currency translation hurt sales by 1%.</p>
<div class="chart_embed">
<h3>IDEX Corporation Price, Consensus and EPS Surprise</h3>
<p><img alt="IDEX Corporation Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/43/1722510887.png" style="height:265px; width:583px" title="" /></p>
<p>IDEX Corporation price-consensus-eps-surprise-chart | IDEX Corporation Quote</p>
</div>
<h3>Margin Profile</h3>
<p>IDEX&#39;s cost of sales decreased 5.9% year over year to $440.4 million. The gross profit was $366.8 million, down 3% year over year. The gross margin was 45.4% compared with 44.7% in the year-ago quarter.</p>
<p>Selling, general and administrative expenses increased 4.9% year over year to $182.8 million. Adjusted EBITDA decreased 6.9% year over year to $224.2 million. The adjusted EBITDA margin decreased 60 bps year over year to 27.8%.</p>
<p>The operating income was $182.7 million, down 8.7% year over year. The operating margin was 22.6%, down 100 bps year over year. Interest expenses (net) decreased 39.1% year over year to $8.1 million.</p>
<h3>Balance Sheet and Cash Flow</h3>
<p>While exiting the second quarter, IDEX&#39;s cash and cash equivalents were $700.7 million compared with $534.3 million at the end of fourth-quarter 2023. Long-term borrowings (net) were $1.30 billion compared with $1.33 billion at the end of fourth-quarter 2023.</p>
<p>In the first six months of 2024, IDEX generated net cash of $290.2 million from operating activities, up 0.4% from the year-ago period. Capital expenditures were $35.9 million compared with $48.2 million in the first six months of 2023. In the same period, free cash flow was $254.3 million, up 5.5% year over year.</p>
<p>Idex paid out dividends totaling $100.7 million in the first six months of 2024, up 7.2% year over year.</p>
<h3>Outlook</h3>
<p>For the third quarter, IDEX anticipates adjusted earnings to be in the band of $1.85-$1.90 per share.</p>
<p>On a GAAP basis, IEX predicts earnings to be in the range of $1.61-$1.66 per share and a 0-1% increase in organic sales from the respective year-ago readings.</p>
<p>For 2024, IDEX anticipates adjusted earnings to be $7.80-$7.90 per share, down from the earlier projected range of $8.15 - $8.45. The figure indicates a decrease from earnings of $8.22 per share reported in 2023. On a GAAP basis, earnings are predicted to be $6.85-$6.95 per share, down from the earlier guided range of $7.13-$7.43.</p>
<p>Organic sales are predicted to decline 1-2% compared with the 0-2% decline guided earlier.</p>
<h3>Zacks Rank &amp; Stocks to Consider</h3>
<p>IDEX currently carries a Zacks Rank #4 (Sell). Some better-ranked companies from the Industrial Products sector have been discussed below:</p>
<p><strong>Kadant Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kai#NYSE">KAI</a>) presently sports a Zacks Rank #1 (Strong Buy).</p>
<p>It has a trailing four-quarter average earnings surprise of 18%.</p>
<p>The Zacks Consensus Estimate for KAI&#39;s 2024 earnings has increased 0.2% in the past 60 days.</p>
<p><strong>Flowserve Corporation</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fls#NYSE">FLS</a>) currently carries a Zacks Rank #2 (Buy). FLS delivered a trailing four-quarter average earnings surprise of 18.2%.</p>
<p>In the past 60 days, the consensus estimate for Flowserve&#39;s 2024 earnings has increased 0.8%.</p>
<p><strong>Emerson Electric Co. </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/emr#NYSE">EMR</a>) presently carries a Zacks Rank of 2. The company delivered a trailing four-quarter average earnings surprise of 10.7%.</p>
<p>In the past 60 days, the Zacks Consensus Estimate for EMR&#39;s 2024 earnings has increased 0.4%.</p>
<p><a href="https://www.zacks.com/stock/news/2313904/idex-iex-q2-earnings-top-estimates-sales-miss-24-view-down?cid=CS-BENZ-FT-analyst_blog|earnings_article-2313904">To read this article on Zacks.com click here.</a></p>


IDEX Q2 Earnings Top Estimates, Sales Miss, '24 View Down

<p>DA Davidson  analyst Kurt Yinger   maintains Kadant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>) with a Neutral and raises the price target from $290 to $300.</p>


Price Target

DA Davidson Maintains Neutral on Kadant, Raises Price Target to $300

<p><strong>Summary and Outlook</strong><br /><br />"With our excellent start to the year and ability to generate strong cash flows, we are well positioned to capitalize on new opportunities that may emerge in the second half of 2024," Mr. Powell continued. "We expect industrial demand in the second half of the year to be similar to the first half of the year, despite persistent economic headwinds in certain regions. We are raising the low end of our revenue and adjusted EPS guidance for the full year and now expect revenue of $1.045 to $1.065 billion in 2024, revised from our previous guidance of $1.040 to $1.065 billion. Our adjusted EPS guidance for 2024 is now $9.80 to $10.05, revised from our previous guidance of $9.75 to $10.05. The 2024 adjusted EPS guidance excludes $0.60 of acquisition-related costs, revised from $0.36 of acquisition-related costs in our previous guidance. We now expect GAAP EPS of $9.20 to $9.45 in 2024, revised from our previous GAAP EPS guidance of $9.39 to $9.69. For the third quarter of 2024, we expect revenue of $257 to $269 million, GAAP EPS of $2.27 to $2.39 and, after excluding $0.09 of acquisition-related costs, adjusted EPS of $2.36 to $2.48."</p>


Guidance

Kadant Sees Q3 EPS $2.36-$2.48 Vs $2.67 Est.; Revenue $257M-$269M Vs $273.88M Est.; Raises FY24 EPS From $9.75-$10.05 To $9.80-$10.05 Vs $10.03 Est.; Revenue From $1.04B-$1.065B To $1.045B-$1.065B Vs $1.06B Est.

<p>Kadant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>) reported quarterly earnings of $2.81 per share which beat the analyst consensus estimate of $2.43 by 15.64 percent. This is a 10.63 percent increase over earnings of $2.54 per share from the same period last year.  The company reported quarterly sales of $274.76 million which beat the analyst consensus estimate of $263.41 million by 4.31 percent.  This is a 12.12 percent increase over sales of $245.05 million the same period last year.</p>


Kadant Q2 Adj $2.81 Beats $2.43 Estimate, Sales $274.76M Beat $263.41M Estimate

<p>For those looking to find strong Industrial Products stocks, it is prudent to search for companies in the group that are outperforming their peers. <strong>Barnes Group</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/b#NYSE">B</a>) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company&#39;s year-to-date performance in comparison to the rest of the Industrial Products sector should help us answer this question.</p>
<p>Barnes Group is one of 218 individual stocks in the Industrial Products sector. Collectively, these companies sit at #6 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.</p>
<p>The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Barnes Group is currently sporting a Zacks Rank of #2 (Buy).</p>
<p>Over the past three months, the Zacks Consensus Estimate for B&#39;s full-year earnings has moved 2.7% higher. This means that analyst sentiment is stronger and the stock&#39;s earnings outlook is improving.</p>
<p>According to our latest data, B has moved about 33.4% on a year-to-date basis. In comparison, Industrial Products companies have returned an average of 8.7%. This means that Barnes Group is outperforming the sector as a whole this year.</p>
<p>Another stock in the Industrial Products sector, <strong>Kadant</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kai#NYSE">KAI</a>), has outperformed the sector so far this year. The stock&#39;s year-to-date return is 21.1%.</p>
<p>For Kadant, the consensus EPS estimate for the current year has increased 0.5% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).</p>
<p>Looking more specifically, Barnes Group belongs to the Manufacturing - General Industrial industry, which includes 44 individual stocks and currently sits at #73 in the Zacks Industry Rank. On average, stocks in this group have gained 9.6% this year, meaning that B is performing better in terms of year-to-date returns. Kadant is also part of the same industry.</p>
<p>Investors with an interest in Industrial Products stocks should continue to track Barnes Group and Kadant. These stocks will be looking to continue their solid performance.</p>
<p><a href="https://www.zacks.com/stock/news/2304354/is-barnes-group-b-stock-outpacing-its-industrial-products-peers-this-year?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_1-2304354">To read this article on Zacks.com click here.</a></p>


<p>Across the recent three months, 4 analysts have shared their insights on Kadant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>), expressing a variety of opinions spanning from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $360.0, a high estimate of $360.00, and a low estimate of $360.00. No alteration is observed as the current average remains at the previous average price target. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1719410473_0.png" alt="price target chart" /></p>
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Kadant by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gary Prestopino</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$360.00</td>
<td>$360.00</td>
</tr>
<tr>
<td>Gary Prestopino</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$360.00</td>
<td>$360.00</td>
</tr>
<tr>
<td>Gary Prestopino</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$360.00</td>
<td>$360.00</td>
</tr>
<tr>
<td>Gary Prestopino</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$360.00</td>
<td>$360.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Kadant. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Kadant compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of Kadant's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Kadant's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/KAI/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Kadant analyst ratings.</strong></a></p>
<h2>Get to Know Kadant Better</h2>
<p>Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, &amp; filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence with sizable revenue from the U.S., Europe, Asia, and Canada.</p>
<h3>Financial Milestones: Kadant's Journey</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Kadant's remarkable performance in 3 months is evident. As of 31 March, 2024, the company achieved an impressive revenue growth rate of <strong>8.36%</strong>. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> Kadant's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>9.92%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Kadant's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>3.17%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Kadant's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>1.91%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.4</strong>.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Navigating 4 Analyst Ratings For Kadant

<p>Barrington Research  analyst Gary Prestopino   maintains Kadant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>) with a Outperform and maintains $360 price target.</p>


Barrington Research Maintains Outperform on Kadant, Maintains $360 Price Target

<p><strong>Kadant's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>) short percent of float has risen 15.28% since its last report. The company recently reported that it has <strong>1.32 million shares sold short</strong>, which is 12.9% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 17.25 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Kadant Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1718802021_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Kadant has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Kadant's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Kadant's peer group average for short interest as a percentage of float is 4.82%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

(KAI) - Analyzing Kadant's Short Interest

Buybacks

Kadant Authorizes Up To $50M Share Repurchase

<p>In the preceding three months, 4 analysts have released ratings for Kadant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $345.0, a high estimate of $360.00, and a low estimate of $300.00. Marking an increase of 1.47%, the current average surpasses the previous average price target of $340.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714582827_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Kadant. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gary Prestopino</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$360.00</td>
<td>$360.00</td>
</tr>
<tr>
<td>Gary Prestopino</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$360.00</td>
<td>$360.00</td>
</tr>
<tr>
<td>Gary Prestopino</td>
<td>Barrington Research</td>
<td>Raises</td>
<td>Outperform</td>
<td>$360.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Gary Prestopino</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$300.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Kadant. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Kadant compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Kadant's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>To gain a panoramic view of Kadant's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/KAI/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Kadant analyst ratings.</strong></a></p>
<h2>Discovering Kadant: A Closer Look</h2>
<p>Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, &amp; filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence with sizable revenue from the U.S., Europe, Asia, and Canada.</p>
<h3>Understanding the Numbers: Kadant's Finances</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Kadant showcased positive performance, achieving a revenue growth rate of <strong>2.83%</strong> as of 31 December, 2023. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.</p>
<p><strong>Net Margin:</strong> Kadant's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>11.48%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Kadant's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>3.64%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>2.35%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Kadant's debt-to-equity ratio is below the industry average. With a ratio of <b>0.14</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Forecasting The Future: 4 Analyst Projections For Kadant

Kadant Sees Q2 2024 Adj. EPS $2.40-$2.50 Vs $2.53 Est.; Revenue $258M-$266M Vs $266.104M Est.

Kadant Maintains FY24 Adj. EPS $9.75-$10.05 Vs $9.81 Est.; Revenue $1.040B-$1.065B Vs $1.063B Est.

<p>Kadant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>) reported quarterly earnings of $2.38 per share which beat the analyst consensus estimate of $1.88 by 26.6 percent.  The company reported quarterly sales of $249.000 million which beat the analyst consensus estimate of $246.115 million by 1.17 percent.  This is a 8.37 percent increase over sales of $229.758 million the same period last year.</p>


Kadant Q1 2024 Adj EPS $2.38 Beats $1.88 Estimate, Sales $249.000M Beat $246.115M Estimate

<p>It was reported on March 5, that <strong>JONATHAN PAINTER</strong>, Director at <strong>Kadant</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>) executed a significant insider sell, according to an SEC filing.</p>
<p><strong>What Happened:</strong> PAINTER's recent move involves selling 7,000 shares of <strong>Kadant</strong>. This information is documented in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000886346/000088634624000034//Archives/edgar/data/886346/000088634624000034/0000886346-24-000034-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday. The total value is $2,311,761.</p>
<p>During Tuesday's morning session, <strong>Kadant</strong> shares down by 0.0%, currently priced at $326.29.</p>
<h3>Unveiling the Story Behind Kadant</h3>
<p>Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, &amp; filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence with sizable revenue from the U.S., Europe, Asia, and Canada.</p>
<h3>Kadant's Economic Impact: An Analysis</h3>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Kadant showcased positive performance, achieving a revenue growth rate of <strong>2.83%</strong> as of 31 December, 2023. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Profitability Metrics:</strong></p>
<ul>
<li>
<p><strong>Gross Margin:</strong> The company excels with a remarkable gross margin of <strong>42.73%</strong>, indicating superior cost efficiency and profitability compared to its industry peers.</p>
</li>
<li>
<p><strong>Earnings per Share (EPS):</strong> Kadant's EPS is notably higher than the industry average. The company achieved a positive bottom-line trend with a current EPS of <strong>2.34</strong>.</p>
</li>
</ul>
<p><strong>Debt Management:</strong> Kadant's debt-to-equity ratio is below the industry average at <strong>0.14</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<p><strong>Market Valuation:</strong></p>
<ul>
<li>
<p><strong>Price to Earnings (P/E) Ratio:</strong> The Price to Earnings ratio of <b><strong>32.96</strong></b> is lower than the industry average, indicating potential undervaluation for the stock.</p>
</li>
<li>
<p><strong>Price to Sales (P/S) Ratio:</strong> A higher-than-average P/S ratio of <strong>4.0</strong> suggests overvaluation in the eyes of investors, considering sales performance.</p>
</li>
<li>
<p><strong>EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization):</strong> Kadant's EV/EBITDA ratio stands at <strong>19.09</strong>, surpassing industry benchmarks. This places the company in a position with a higher-than-average market valuation.</p>
</li>
</ul>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><a href="https://www.schwab.com/brokerage?aff=XEC"><em>Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</em></a></p>
<h3>The Relevance of Insider Transactions</h3>
<p>Considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.</p>
<p>From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.</p>
<p>A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.</p>
<p>While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.</p>
<h3>Important Transaction Codes</h3>
<p>Surveying the realm of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often give prominence to those unfolding in the open market, systematically detailed in Table I of the Form 4 filing. A <strong>P</strong> in Box 3 indicates a purchase, while <strong>S</strong> signifies a sale. Transaction code <strong>C</strong> denotes the conversion of an option, and transaction code <strong>A</strong> denotes a grant, award, or other acquisition of securities from the company.</p>
<p><a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000886346"><strong>Check Out The Full List Of Kadant's Insider Trades.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


JONATHAN PAINTER Implements A Sell Strategy: Offloads $2.31M In Kadant Stock

<p>Barrington Research  analyst Gary Prestopino   maintains Kadant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>) with a Outperform and raises the price target from $300 to $360.</p>


Barrington Research Maintains Outperform on Kadant, Raises Price Target to $360

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Short-squeeze stocks represent one of the boldest forms of contrarianism available. Simply put, it&rsquo;s a showdown between the bears that are attempting to profit from the downturn of a public enterprise. In their minds, by eliminating weak players from the market, it improves Wall Street&rsquo;s &ldquo;gene pool,&rdquo; if you will. On the other end, the bulls can play the savior role.</p>



<p>What makes short-squeeze stocks so compelling, though, is the incentivization profile. On the pessimistic side, speculators make their money pocketing the difference between the borrowed securities selling price versus the subsequent buy-back price. If the latter is lower than the former, the trader picks up a profit. However, if the latter is higher, than the speculator incurs a loss.</p>



<p>Now, unlike other types of market losses, the red ink on a short trade is uncapped. That&rsquo;s because there&rsquo;s no limit to how high a security can rise. Therefore, a panic to cover bearish positions (by buying to close) can yield a dramatic lift in the share price, called a short squeeze. With that in mind, below are short-squeeze stocks to consider.</p>



<h2>Kadant (KAI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/07/short-squeeze-stocks-300x169.jpg" alt="Man squeezing water out of a rag representing FNGR stock. Short Squeeze Stocks"><div>Source: Alextype/Shutterstock.com</div></div><p>Operating in the specialty industrial machinery sector, <strong>Kadant</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/kai-stock-quote/"><strong>KAI</strong></a>) supplies various technologies and engineered systems worldwide. Primarily, the company focuses on fluid-handling systems and equipment, such as rotary joints and syphons. It also features other relevancies, including innovations in industrial automation and control. Still, KAI has fluctuated in market value.</p>



<p>Nevertheless, investors will want to keep close tabs on Kadant. According to Fintel, KAI stock carries a <a href="https://fintel.io/ss/us/kai">short interest of 12.32% of its float</a>. That&rsquo;s elevated but not intensely remarkable. However, the equity unit&rsquo;s short-interest ratio stands at nearly 33 days to cover. That&rsquo;s the number of trading sessions it would take for the bears to close out their short exposure.</p>



<p>If a panic materializes, the bears will be anxious to seal off their vulnerability. They&rsquo;re even more motivated to do this with Kadant, noting that KAI stock has gained 13% in the trailing month. In addition, the company is projected to see revenue growth of nearly 11% to $1.06 billion by year&rsquo;s end. It&rsquo;s one of the short-squeeze stocks to consider.</p>



<h2>AirSculpt Technologies (AIRS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/01/oversold-stocks-to-buy-300x169.jpg" alt="man in suit holding a tablet with graphic above showing oversold stocks to buy"><div>Source: undefined undefined / Getty Images</div></div><p>Operating in the medical care facilities industry, <strong>AirSculpt Technologies</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/airs-stock-quote/"><strong>AIRS</strong></a>) along with its subsidiaries provides body contouring procedure services. It offers its namesake solution, which is a next-generation body contouring protocol that removes unwanted fat and tightens skin. Best of all, the procedure is minimally invasive.</p>



<p>Still, many investors are skeptical about AIRS stock. Since the start of the year, shares tumbled more than 36%. As a result, the<a href="https://fintel.io/ss/us/airs"> short interest of AirSculpt comes in at 16.26% of its float</a>. However, the short-interest ratio is truly remarkable, standing at almost 56 days to cover. We&rsquo;re basically talking business days here so that&rsquo;s a lengthy period of vulnerability for the bears.</p>



<p>If AIRS stock starts shooting higher for whatever reason, a panic could easily materialize. It&rsquo;s worth pointing out that in the business week ended July 12, the equity gained more than 16%. In addition, analysts project that AirSculpt can post earnings per share of 24 cents this year. That&rsquo;s up from last year&rsquo;s loss of 8 cents. It&rsquo;s a candidate for short-squeeze stocks.</p>



<h2>Trupanion (TRUP)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/09/trup1600-300x169.jpg" alt="a veterinarian holding a small white dog"><div>Source: Shutterstock</div></div><p>Falling under the specialty insurance segment, <strong>Trupanion</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/trup-stock-quote/"><strong>TRUP</strong></a>) in my opinion represents a clear-cut case for short-squeeze stocks. With its subsidiaries, Trupanion provides medical insurance for cats and dogs on a monthly subscription basis. What&rsquo;s enticing here is the fundamental catalyst: Americans (and citizens of other countries) love their pets.</p>



<p>It&rsquo;s too bad that Wall Street doesn&rsquo;t love TRUP stock. Since the beginning of this year, shares gained less than 2%. Over the past five years, it went nowhere if you had held throughout the entire period: TRUP lost a bit more than 9%. Still, what&rsquo;s intriguing here is that the equity&rsquo;s <a href="https://fintel.io/ss/us/trup">short interest</a> stands at nearly 33% of its float. Further, the short-interest ratio is 31.41 days to cover.</p>



<p>If you&rsquo;re an extreme contrarian, these figures may have you drooling. What you have is an extremely high short interest along with a blisteringly hot short ratio. You&rsquo;ve basically got the bears boxed in if the position moves against them. Analysts are calling for revenue to expand by 13.7% to $1.26 billion in fiscal 2024.</p>



<h2>Westrock Coffee (WEST)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/09/coffee_1600-300x169.jpg" alt="NUZE Stock. A photo of a cup of coffee and some coffee beans and a towel on a wooden table. Coffee stocks"><div>Source: Evgeny Karandaev/ShutterStock.com</div></div><p>Falling under the consumer defensive space, <strong>Westrock Coffee</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/west-stock-quote/"><strong>WEST</strong></a>) operates in the packaged foods industry. <a href="https://finance.yahoo.com/quote/WEST/profile/">Per its public profile</a>, Westrock is an integrated coffee, tea, flavors, extracts and ingredients provider. It mainly serves the U.S. though it also covers other international markets. With the growing demand for coffee worldwide, WEST stock should be intriguing for many investors.</p>



<p>Unfortunately, Wall Street doesn&rsquo;t have much love for Westrock. Since the beginning of January, shares lost about 2% of equity value. In the past 52 weeks, they&rsquo;re down 8%. Those aren&rsquo;t great statistics. At the same time, contrarian investors should consider the bearish profile. Short interest stands at a whopping 54.85%. That&rsquo;s extreme and then some. Also, the short ratio hits 33.27 days to cover.</p>



<p>Again, what we have here is a situation where the bears are locked in. If the position moves against them, a big panic can materialize. After all, 33 business days is a long time. Plus, experts project 9.4% sales growth to $945.67 million this year. It&rsquo;s one of the short-squeeze stocks to consider.</p>



<h2>Mondee Holdings (MOND)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/06/air-travel-1600-300x169.png" alt="Plane travel. Man standing in airport waiting for flight. travel stocks to buy"><div>Source: Olena Yakobchuk / Shutterstock</div></div><p>Operating in the consumer cyclical sector, <strong>Mondee Holdings</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/mond-stock-quote/"><strong>MOND</strong></a>) specifically covers the travel services realm. <a href="https://finance.yahoo.com/quote/MOND/profile/">Per its corporate profile</a>, Mondee operates as a travel technology firm for the leisure travel space. Primarily, the company focuses on the sale of airline tickets through its platform. Thanks to people prioritizing their vacation time post-pandemic, MOND stock should be intriguing.</p>



<p>However, the market has had a tough time deciphering what the underlying business is all about. On a year-to-date basis, MOND incurred a loss of more than 3%. Further, the trading action has been incredibly choppy throughout 2024 so far. Still, MOND could attract contrarians with its short interest of just under 21% of its float. Further, the short interest ratio stands at 42.58 days to cover.</p>



<p>As with so many of the other short-squeeze stocks on this list, an upside panic can lead to more upside as the bears rush to cover their short positions. Experts also see Mondee hitting $255.09 million in sales for fiscal 2024, implying 14.8% growth from last year.</p>



<h2>scPharmaceuticals (SCPH)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/03/pharmaceuticals_tnxp_1600-300x169.png" alt="medicine research, pharmaceutical background, LJPC stock"><div>Source: Sisacorn / Shutterstock.com</div></div><p>Falling under the biotechnology space, <strong>scPharmaceuticals</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/scph-stock-quote/"><strong>SCPH</strong></a>) engages in the development and commercialization of various pharmaceutical products. Its lead <a href="https://finance.yahoo.com/quote/SCPH/profile/">product candidate is Furoscix</a>, which aims to treat congestion due to fluid overload in adults with chronic heart failure and kidney disease. Given the <a href="https://www.cdc.gov/pcd/issues/2024/23_0267.htm#:~:text=Over%20the%20past%202%20decades,at%20least%205%20(5).">rise of incidences of chronic disease</a>, scPharmaceuticals should &ldquo;benefit&rdquo; (for lack of a better word) from this dynamic.</p>



<p>However, the market seems to have other ideas. Since the start of the year, SCPH stock incurred a loss of more than 29%. In the past 52 weeks, it&rsquo;s down almost 47%. Still, this could be a case of bad news being good news, especially for contrarians. <a href="https://fintel.io/ss/us/scph">The short interest of SCPH stands at 36% of its float</a>. Also, the short-interest ratio clocks in at 50.5 days to cover.</p>



<p>If shares start flying higher, the bears could be locked in. Therefore, the contrarian bulls are possibly licking their lips. Analysts believe that the biotech could post sales of $39.34 million this year. If so, that would imply a growth rate of 189.4%. This is one of the more tempting short-squeeze stocks.</p>



<h2>Verrica Pharmaceuticals (VRCA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/12/vrca1600-300x169.png" alt="Shot of Sterile Pharmaceutical Manufacturing Laboratory where Scientists in Protective Coverall's Do Research, Quality Control and Work on the Discovery of new Medicine. VRCA stock"><div>Source: Gorodenkoff / Shutterstock.com</div></div><p>Ending this list with another healthcare-related entity, <strong>Verrica Pharmaceuticals</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/vrca-stock-quote/"><strong>VRCA</strong></a>) is a clinical-stage dermatology therapeutics firm. It develops medications for the treatment of skin diseases. Right now, it features a therapeutic called Ycanth (VP-102), which is in Phase 3 trials for the treatment of common warts. Given the sensitive needs to address such skin conditions, Verrica should be a top player.</p>



<p>Sure enough, VRCA stock has gained over 25% of market value since the start of the year. However, it&rsquo;s been a choppy ride. Those who got in during this year&rsquo;s highs are still underwater, implying lingering pessimism. This dynamic explains the <a href="https://fintel.io/ss/us/vrca">high short interest</a> of 26%. Not only that, VRCA&rsquo;s short interest ratio lands at 32.83 days to cover.</p>



<p>However, if shares start swinging higher for whatever reason, the bears would likely find themselves in trouble. It takes a while to unwind a short ratio of 33 days. Further, analysts anticipate massive growth in the coming years. Fiscal 2024 sales could hit $24.71 million, up 382.2%. And fiscal 2025 may see revenue up at $70.3 million. It&rsquo;s one of the short-squeeze stocks to keep on your radar.</p>



<p><em>On the date of publication, Josh Enomoto</em><em> did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;</em><em>The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em><em></em></p>
<div><p>A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/07/7-short-squeeze-stocks-that-could-beat-down-the-bears/">7 Short-Squeeze Stocks That Could Beat Down the Bears</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

7 Short-Squeeze Stocks That Could Beat Down the Bears

Kadant Non-GAAP EPS of $2.81 beats by $0.38, revenue of $275M beats by $11.48M

The latest update is out from Kadant (KAI). On July 31, 2024, investors and financial enthusiasts have the opportunity to join a webcast and confer...

Kadant Q2 Financial Performance Webcast and Insights

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Kadant</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/kai-stock-quote/"><strong>KAI</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Kadant reported earnings per share of $2.81. This was above the analyst estimate for EPS of $2.43.</li><li>The company reported revenue of $274.77 million.</li><li>This was 4.31% better than the analyst estimate for revenue of $263.41 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/07/kai-stock-earnings-kadant-for-q2-of-2024/">KAI Stock Earnings: Kadant Beats EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

KAI Stock Earnings: Kadant Beats EPS, Beats Revenue for Q2 2024

D.A. Davidson analyst Kurt Yinger maintained a Hold rating on Kadant (KAI – Research Report) today and set a price target of $290.00. The company's...

D.A. Davidson Keeps Their Hold Rating on Kadant (KAI)

Kadant Inc (KAI) Q2 2024 Earnings Call Transcript

In a report released today, Walter Liptak from Seaport Global maintained a Hold rating on Kadant (KAI – Research Report). The company's shares clos...

Seaport Global Sticks to Its Hold Rating for Kadant (KAI)

Kadant Inc. supplies technologies and engineered systems worldwide.

Chart Of The Day: Kadant - 18 Advances In The Last 20 Trading Sessions

Dividend Champion, Contender, And Challenger Highlights: Week Of August 4

Kadant declares $0.32 dividend

AIRS

AROW

BMRC

BPRN

CARR

CBAN

CHCT

CIVB

COST

CSWI

CTVA

CWEN

FBIZ

FBMS

FCBC

FSBW

GABC

HBCP

HESM

HFWA

HIFS

HWKN

LFUS

LSTR

MAIN

MCHP

MOND

MPLX

NIDB

NXST

ORRF

OTEX

OVLY

PAYX

RUSHA

SBFG

SCPH

SIRI

SMBC

SPFI

STBA

SWKS

TRUP

TSBK

VALU

VRCA

WDFN

WEST

WING

WSFS

WTFC

WTRG

Dividends

Press Releases

Kadant Declares Cash Dividend

Kadant to Hold Earnings Conference Call on Wednesday, May 1, 2024

Kadant Reports First Quarter 2024 Results

Kadant Authorizes Share Repurchase

Kadant Acquires Dynamic Sealing Technologies

Kadant to Hold Earnings Conference Call on Wednesday, July 31, 2024

Kadant Reports Second Quarter 2024 Results

General

Kadant Named to Newsweek's List of America's Greatest Workplaces for Parents and Families 2024

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Kadant

Kadant (KAI) Forecast

Kadant (NYSE:KAI) Stock, Quote.Headers.trade-ideas